Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study

被引:12
作者
Cheng, Ching-Yao [1 ,2 ]
Chen, Cheng-Hsu [3 ,4 ,5 ]
Wu, Ming-Fen [1 ]
Wu, Ming-Ju [3 ,6 ,7 ,8 ]
Chen, Jun-Peng [9 ]
Liu, Ying-Mei [1 ]
Hou, Yu-Chi [2 ]
Wang, Hue-Yu [10 ,11 ]
机构
[1] Taichung Vet Gen Hosp, Dept Pharm, Taichung 40705, Taiwan
[2] China Med Univ, Sch Pharm, Taichung 40402, Taiwan
[3] Taichung Vet Gen Hosp, Div Nephrol, Dept Internal Med, Taichung 40705, Taiwan
[4] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan
[5] China Med Univ, Sch Med, Coll Med, Taichung 40402, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung 40402, Taiwan
[7] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung 40402, Taiwan
[8] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan
[9] Taichung Vet Gen Hosp, Biostat Task Force, Taichung 40705, Taiwan
[10] Chi Mei Med Ctr, Dept Pharm, Tainan 71004, Taiwan
[11] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan 71710, Taiwan
关键词
immunosuppressant; post-transplant diabetes mellitus; risk factor; survival rate; NEW-ONSET HYPERGLYCEMIA; KIDNEY-TRANSPLANTATION; TACROLIMUS; IMMUNOSUPPRESSION; METAANALYSIS; GUIDELINES; MANAGEMENT; RECIPIENTS; SIROLIMUS; MORTALITY;
D O I
10.3390/ijerph17124581
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Post-transplant diabetes mellitus (PTDM) is associated with infection, cardiovascular morbidity, and mortality. A retrospective cohort study involving patients who underwent renal transplantation in a transplantation center in Taiwan from January 2000 to December 2018 was conducted to investigate the incidence and risk factors of PTDM and long-term patient and graft survival rates. High age (45-65 vs. <45 years, adjusted odds ratio (aOR) = 2.90, 95% confidence interval (CI) = 1.64-5.13,p< 0.001), high body mass index (>27 vs. <24 kg/m(2), aOR = 5.35, 95% CI = 2.75-10.42,p< 0.001), and deceased organ donor (cadaveric vs. living, aOR = 2.01, 95% CI = 1.03-3.93,p= 0.04) were the three most important risk factors for the development of PTDM. The cumulative survival rate of patients and allografts was higher in patients without PTDM than in those with PTDM(p= 0.007 and 0.041, respectively). Concurrent use of calcineurin inhibitors and mammalian target of rapamycin inhibitors (mTORis) decreased the risk of PTDM (tacrolimus vs. tacrolimus with mTORi, aOR = 0.28, 95% CI = 0.14-0.55,p< 0.001). Investigating PTDM risk factors before and modifying immunosuppressant regimens after transplantation may effectively prevent PTDM development.
引用
收藏
页码:1 / 12
页数:11
相关论文
共 33 条
[1]   Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials [J].
Abuissa, H ;
Jones, PG ;
Marso, SP ;
O'Keefe, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) :821-826
[2]   Post-Renal Transplantation Outcomes in Elderly Patients Compared to Younger Patients in the Setting of Early Steroid Withdrawal [J].
Alsheikh, Razan ;
Gabardi, Steven .
PROGRESS IN TRANSPLANTATION, 2018, 28 (04) :322-329
[3]   Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression [J].
Baron, Pedro W. ;
Infante, Sergio ;
Peters, Regina ;
Tilahun, Jerusalem ;
Weissman, Jill ;
Delgado, Lauren ;
Kore, Arputharaj ;
Beeson, W. Lawrence ;
de Vera, Michael .
ANNALS OF TRANSPLANTATION, 2017, 22 :309-314
[4]   Post-Kidney-Transplant Diabetes: Evaluation of Risk Factors [J].
Cascais de Sa, D. ;
Santos, L. ;
Rodrigues, L. ;
Romaozinho, C. ;
Guedes Marques, M. ;
Macario, F. ;
Bastos, M. ;
Baptista, C. ;
Alves, R. ;
Figueiredo, A. .
TRANSPLANTATION PROCEEDINGS, 2019, 51 (05) :1597-1600
[5]   New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation [J].
Cosio, FG ;
Kudva, Y ;
van der Velde, M ;
Larson, TS ;
Textor, SC ;
Griffin, MD ;
Stegall, MD .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2415-2421
[6]   Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years [J].
Cosio, FG ;
Pesavento, TE ;
Osei, K ;
Henry, ML ;
Ferguson, RM .
KIDNEY INTERNATIONAL, 2001, 59 (02) :732-737
[7]   New-onset diabetes after transplantation: 2003 International Consensus Guidelines [J].
Davidson, J ;
Wilkinson, A ;
Dantal, J ;
Dotta, F ;
Haller, H ;
Hernández, D ;
Kasiske, BL ;
Kiberd, B ;
Krentz, A ;
Legendre, C ;
Marchetti, P ;
Markell, M ;
van der Woude, FJ ;
Wheeler, DC .
TRANSPLANTATION, 2003, 75 (10) :SS3-SS24
[8]   Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria [J].
Eide, Ivar Anders ;
Halden, Thea Anine Strom ;
Hartmann, Anders ;
Asberg, Anders ;
Dahle, Dag Olav ;
Reisaeter, Anna Varberg ;
Jenssen, Trond .
TRANSPLANT INTERNATIONAL, 2016, 29 (05) :568-578
[9]   Development of diabetes mellitus following kidney transplantation: A Canadian experience [J].
Gourishankar, S ;
Jhangri, GS ;
Tonelli, M ;
Wales, LH ;
Cockfield, SM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) :1876-1882
[10]   2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J].
Jensen, Michael D. ;
Ryan, Donna H. ;
Apovian, Caroline M. ;
Ard, Jamy D. ;
Comuzzie, Anthony G. ;
Donato, Karen A. ;
Hu, Frank B. ;
Hubbard, Van S. ;
Jakicic, John M. ;
Kushner, Robert F. ;
Loria, Catherine M. ;
Millen, Barbara E. ;
Nonas, Cathy A. ;
Pi-Sunyer, F. Xavier ;
Stevens, June ;
Stevens, Victor J. ;
Wadden, Thomas A. ;
Wolfe, Bruce M. ;
Yanovski, Susan Z. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) :2985-3025